Cardiovascular risk management in gout patients: do patients benefit from screening in secondary care?
Authors' conclusion
Recommendations to patients and the general practitioner (GP) alone did not result in overall improvement of traditional CVD risk factors nor the 10-year CVD risk.
Study context
- Population
- Patients with gout in secondary care, Reade Amsterdam
- Exposure
- Baseline vs 1 year after cardiovascular disease (CVD) risk screening
- Outcome
- 10-year CVD risk (NL-SCORE) and effect of CVD risk screening on it
- Follow-up
- 1 year
Methodological detailssingle-group, baseline and 1-year follow-up, paired sample t-test and McNemar test
- Single-group
- Baseline and 1-year follow-up
- Paired sample t-test and McNemar test
Main finding
As reported in the abstract
10-year CVD risk (NL-SCORE)
High-risk group by NL-SCORE, patients without previous CVD
19%
Observational data: associations, not effects.
Further findings
Prevalence of CVD · 1-year follow-up
- CVD prevalence at baseline
- 16%
- CVD prevalence after 1-year follow-up
- 21%
Traditional CV risk factors · 1 year
- Very high prevalence of traditional CV risk factors
- Decrease in total- and LDL-cholesterol after 1 year
- No decrease in mean BMI, waist-hip ratio or blood pressure
Original publication
Cardiovascular risk management in gout patients: do patients benefit from screening in secondary care? Clin Exp Rheumatol. Published 15 August 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →